Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

Presenter: Jubin Joseph

June 09, 2022

Presentation TVT 2022

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

Presenter: Saif Anwaruddin

June 08, 2022

Presentation TVT 2022

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Presenter: Vinod Thourani

June 08, 2022

Presentation TVT 2022

Alternative Transcatheter Solutions

Presenter: Lauren Ranard

June 08, 2022

Presentation TVT 2022

Frequency, Mechanisms, and Current Management

Presenter: Nir Uriel

June 08, 2022

Presentation TVT 2022

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Presenter: Matti Adam

June 08, 2022

Presentation TVT 2022

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

Presenter: Vinod Thourani

June 08, 2022

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

Real-world experience with the SAPIEN 3 Ultra TAVR: A propensity matched analysis from the United States

Presenter: Tamim Nazif

June 20, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Presenter: Guilherme F. Attizzani

June 20, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

Advertisement

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Minorities, Poorer Patients Missing Out on Structural Heart Care

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Alternative Transcatheter Solutions

Frequency, Mechanisms, and Current Management

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Real-world experience with the SAPIEN 3 Ultra TAVR: A propensity matched analysis from the United States

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Newer TAVR Devices Reassure in Failed Surgical Valves

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content